Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
2.380
+0.260 (12.26%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Indaptus Therapeutics Market Cap
Indaptus Therapeutics has a market cap or net worth of $317.12 million as of October 2, 2026. Its market cap has increased by 8,088.20% in one year.
Market Cap
317.12M
Enterprise Value
305.56M
1-Year Change
8,088.20%
Ranking
Category
Stock Price
$2.38
ChartMarket Cap Chart
Since August 4, 2021, Indaptus Therapeutics's market cap has increased from $47.95M to $317.12M, an increase of 561.34%. That is a compound annual growth rate of 44.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 317.12M | 6,123.00% |
| Dec 31, 2025 | 5.10M | -49.63% |
| Dec 31, 2024 | 10.12M | -31.58% |
| Dec 29, 2023 | 14.79M | 21.38% |
| Dec 30, 2022 | 12.18M | -73.92% |
| Dec 31, 2021 | 46.70M | -2.60% |
| Aug 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BridgeBio Oncology Therapeutics | 328.71M |
| Cabaletta Bio | 325.53M |
| Century Therapeutics | 309.64M |
| Clinuvel Pharmaceuticals | 301.59M |
| Abeona Therapeutics | 300.22M |
| Evommune | 299.77M |
| Vanda Pharmaceuticals | 296.87M |
| Rocket Pharmaceuticals | 288.71M |